The Nifty Pharma index rose 1.4% on 8 June, defying the broader market selloff, supported by heavyweight stocks like JB Chemicals and Alkem Laboratories. Despite some losses in others, analysts suggest pharma stocks are resilient during market instability due to consistent healthcare demand.